Literature DB >> 7997714

Reduction in burden of illness: a new efficacy measure for prevention trials.

M N Chang1, H A Guess, J F Heyse.   

Abstract

A new efficacy measure is developed for use in prevention trials of interventions which may affect both disease incidence and disease severity. We assign a severity score to each incident case and sum severity scores over all incident cases within each treatment group to create a burden-of-illness score for each treatment group. Efficacy is evaluated by the difference between the burden-of-illness per randomized subject in the two randomized treatment groups. Since the numbers of summands in each burden-of-illness score is a random variable, standard methods of analysis are not directly applicable. The asymptotic distribution and sampling properties of the net reduction in the burden-of-illness score are derived for trials designed to stop either after a fixed length of follow-up or after the occurrence of a fixed number of cases. We illustrate the method with data from a clinical trial of a human rotavirus vaccine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7997714     DOI: 10.1002/sim.4780131803

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  15 in total

1.  Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data.

Authors:  Peter B Gilbert; Yuying Jin
Journal:  Biostatistics       Date:  2009-10-08       Impact factor: 5.899

2.  Long-term persistence of zoster vaccine efficacy.

Authors:  Vicki A Morrison; Gary R Johnson; Kenneth E Schmader; Myron J Levin; Jane H Zhang; David J Looney; Robert Betts; Larry Gelb; John C Guatelli; Ruth Harbecke; Connie Pachucki; Susan Keay; Barbara Menzies; Marie R Griffin; Carol A Kauffman; Adriana Marques; John Toney; Kathy Boardman; Shu-Chih Su; Xiaoming Li; Ivan S F Chan; Janie Parrino; Paula Annunziato; Michael N Oxman
Journal:  Clin Infect Dis       Date:  2014-11-20       Impact factor: 9.079

3.  Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.

Authors:  K E Schmader; M N Oxman; M J Levin; G Johnson; J H Zhang; R Betts; V A Morrison; L Gelb; J C Guatelli; R Harbecke; C Pachucki; S Keay; B Menzies; M R Griffin; C Kauffman; A Marques; J Toney; P M Keller; X Li; I S F Chan; P Annunziato
Journal:  Clin Infect Dis       Date:  2012-07-24       Impact factor: 9.079

4.  Randomization-Based Inference within Principal Strata.

Authors:  Tracy L Nolen; Michael G Hudgens
Journal:  J Am Stat Assoc       Date:  2011-06       Impact factor: 5.033

5.  LC-MS/MS-based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma.

Authors:  Tsung-Heng Tsai; Ehwang Song; Rui Zhu; Cristina Di Poto; Minkun Wang; Yue Luo; Rency S Varghese; Mahlet G Tadesse; Dina Hazem Ziada; Chirag S Desai; Kirti Shetty; Yehia Mechref; Habtom W Ressom
Journal:  Proteomics       Date:  2015-04-29       Impact factor: 3.984

6.  Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop.

Authors:  Dean Follmann; Ann Duerr; Stephen Tabet; Peter Gilbert; Zoe Moodie; Patricia Fast; Massimo Cardinali; Steve Self
Journal:  J Acquir Immune Defic Syndr       Date:  2007-01-01       Impact factor: 3.731

7.  Area under the curve: a metric for patient subjective responses in episodic diseases.

Authors:  E Lydick; R S Epstein; D Himmelberger; C J White
Journal:  Qual Life Res       Date:  1995-02       Impact factor: 4.147

Review 8.  Statistical Considerations of Food Allergy Prevention Studies.

Authors:  Henry T Bahnson; George du Toit; Gideon Lack
Journal:  J Allergy Clin Immunol Pract       Date:  2017 Mar - Apr

9.  Vaccination against Herpes Zoster and Postherpetic Neuralgia.

Authors:  Michael N Oxman; Myron J Levin
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

10.  Associations of coping strategies with diary based pain variables among Caucasian and African American patients with osteoarthritis.

Authors:  Yvonne M Golightly; Kelli D Allen; Karen M Stechuchak; Cynthia J Coffman; Francis J Keefe
Journal:  Int J Behav Med       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.